---
document_datetime: 2023-09-21 19:59:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fetcroja-epar-all-available-presentations_en.pdf
document_name: fetcroja-epar-all-available-presentations_en.pdf
version: success
processing_time: 0.6239555
conversion_datetime: 2025-12-23 03:14:27.900406
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMA procedure number   | (Invented) name   | Strength   | Pharmaceutical form                              | Route of administration   | Immediate Packaging   | Pack size   |
|------------------------|-------------------|------------|--------------------------------------------------|---------------------------|-----------------------|-------------|
| EU/1/20/1434/001       | Fetcroja          | 1 g        | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 vials    |